Title :
Chemo-thermal approach for efficient ultrasonic tumor treatment with phase change nano droplet
Author :
Kawabata, Kenichi ; Asami, Rei ; Umemura, Shinichiro
Author_Institution :
Central Res. Lab., Hitachi. Ltd., Tokyo, Japan
Abstract :
Phase-change nano-droplet (PCND) was found to promote chemically significant cavitation. PCNDs, which were droplets containing superheated perfluorocarbon and suspended in buffer solution with potassium iodide, were exposed to 1.1-MHz ultrasound with a sequence of periodically applied triggering pulses to generate microbubbles and following continuous-wave (CW) exposures. The chemical activity of ultrasound exposures, measured as the reaction yield of tri-iodide ions was strongly dependent on the interval of the pulses. We found that pulse intervals shorter than 0.03 s were needed to generate chemically significant cavitation. Further, we found that pre-exposure of ultrasound for chemical effects could be performed by using gel phantoms with thermal coagulation indicators, without sacrificing the effect of PCNDs to enhance temperature increase induced by exposure to high intensity focused ultrasound (HIFU). The results we obtained suggested the potential of `chemo-thermal´ therapy for tumors, which sequentially utilizes the chemical and thermal effect of PCNDs.
Keywords :
biomedical ultrasonics; bubbles; gels; phantoms; potassium compounds; radiation therapy; tumours; buffer solution; chemically significant cavitation; chemothermal therapy; continuous wave exposure; gel phantom; high intensity focused ultrasound; microbubbles; phase change nano droplet; potassium iodide; superheated perfluorocarbon; thermal coagulation indicator; ultrasonic tumor treatment; Acoustic measurements; Acoustics; Chemicals; Medical treatment; Phantoms; Ultrasonic imaging; Ultrasonic variables measurement; cavitation; chemical effects; microbubble; nano droplet; phase-change;
Conference_Titel :
Ultrasonics Symposium (IUS), 2011 IEEE International
Conference_Location :
Orlando, FL
Print_ISBN :
978-1-4577-1253-1
DOI :
10.1109/ULTSYM.2011.0003